Evaluation of microRNA-21 expression in serum and stool as a potential biomarker for diagnosis of colorectal cancer:a meta-analysis
Yang LI,Chaohui ZHEN,Kai HUANG,Yan TAN,Furong LI,Kai LING,Yue ZHANG,Xiaofang YU
DOI: https://doi.org/10.3969/j.issn.1009-976X.2016.05.009
2016-01-01
Abstract:Objective To assess the diagnosis value of microRNA-21 in tissues, feces, serum, and plasma for systematic diagnosis of CRC using Meta-analysis. Methods Databases, including Cochrane library, PubMed, EMbase, Google Scholar, and Chinese National Knowledge Infrastructure, were scanned to retrieve relevant articles focusing on microRNA-21 in CRC diagnosis. Articles were then filtered according to the PRISMA statement and assessed by quality assessment of diagnosis accuracy studies-2. Sensitivity (SEN), specificity (SPE), positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio (DOR) were pooled using fixed-effects model or random-effects model. Summary receiver operating characteristic (SROC) curve and area under the curve (AUC) were used to estimate the overall diagnostic performance. Results A total of 15 studies, comprising 1268 CRC patients and 910 healthy controls, were enrolled in this meta-analysis. Forserum miR-21, the pooled DOR, SEN, and SPE were 13.97 (95% CI: 8.44-23.11), 0.73 (95%CI: 0.69-0.77), and 0.83 (95% CI: 0.76-0.89), respectively; for plasma miR-21, the pooled DOR, SEN, and SPE were 8.03 (95% CI: 3.30-19.52), 0.67 (95% CI: 0.60-0.73), and 0.76 (95% CI: 0.69-0.81), respectively; and for fecal miR-21, the pooled DOR, SEN, and SPE were 7.06 (95% CI: 2.17-22.95), 0.33 (95% CI: 0.28-0.37), and 0.91 (95% CI: 0.88-0.93), respectively. Moreover, the AUC values of serum, plasma, and fecal miR-21 in CRC diagnosis were 0.8701, 0.8295, and 0.6742, respectively. Conclusion Circulation miR-21 demonstrates good diagnostic performance, and serum samples are better than plasma samples in CRC diagnosis. For fecal miR-21, the sensitivity is unsatisfactory, but the specificity is favorable in predicting CRC patients.